• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经肌肉阻滞剂的未来。

The future of neuromuscular blocking agents.

机构信息

Klinik für Anaesthesiologie und Intensivmedizin, Technische Universität München, Klinikum Rechts der Isar, Ismaninger Straße, München, Germany.

出版信息

Curr Opin Anaesthesiol. 2020 Aug;33(4):490-498. doi: 10.1097/ACO.0000000000000891.

DOI:10.1097/ACO.0000000000000891
PMID:32628397
Abstract

PURPOSE OF REVIEW

The present review provides a summary of the literature on recent development of new neuromuscular blocking agents and presents clinically well established and new reversal agents.

RECENT FINDINGS

Anesthesiologists are still waiting for the ideal neuromuscular blocking agent with a succinylcholine-like rapid onset and offset without side effects. Recent drug development led to a new series of neuromuscular compounds, called the chlorofumarates such as gantacurium, CW002, and CW011. These drugs have a promising pharmacodynamic profile; importantly, they can rapidly be reversed by L-cysteine adduction without relevant side effects. In addition, a new spectrum of reversal agents are currently examined in preclinical studies: adamgammadex sodium, a modified γ-cyclodextrin derivate that forms an inactive tight inclusion complex with rocuronium or vecuronium and calabadions, capable of reversing both benzylisoquinolines and steroidal neuromuscular blocking agents.

SUMMARY

Although the recent advancements in neuromuscular research are very promising, to date, the presented drugs are currently not available for clinical use. Clinical studies will determine the role of these developments in anesthesia practice. Therefore, well established combinations such as rocuronium-sugammadex are popular in clinical practice to offer quick paralysis for intubation and to optimize surgical conditions, while providing a fast neuromuscular recovery at the end of surgery.

摘要

目的综述

本综述总结了近年来新型神经肌肉阻断剂的研究进展,并介绍了临床上已确立的和新的逆转剂。

最新发现

麻醉师仍在等待具有琥珀胆碱样快速起效和消除作用而无副作用的理想神经肌肉阻断剂。最近的药物开发导致了一系列新的神经肌肉化合物,称为氯代富马酸盐,如加丹曲林、CW002 和 CW011。这些药物具有有前途的药效学特征;重要的是,它们可以通过 L-半胱氨酸加成快速逆转,而没有相关的副作用。此外,目前正在临床前研究中检查一系列新的逆转剂:纳曲胺,一种改良的γ-环糊精衍生物,与罗库溴铵或维库溴铵和 calabadions 形成无活性的紧密包含复合物,能够逆转苯并异喹啉类和甾体神经肌肉阻断剂。

总结

尽管神经肌肉研究的最新进展非常有前景,但迄今为止,所提出的药物目前尚未临床应用。临床研究将确定这些进展在麻醉实践中的作用。因此,罗库溴铵- sugammadex 等已确立的组合在临床实践中很受欢迎,可提供快速插管的麻痹作用,并优化手术条件,同时在手术结束时提供快速的神经肌肉恢复。

相似文献

1
The future of neuromuscular blocking agents.神经肌肉阻滞剂的未来。
Curr Opin Anaesthesiol. 2020 Aug;33(4):490-498. doi: 10.1097/ACO.0000000000000891.
2
New Drug Developments for Neuromuscular Blockade and Reversal: Gantacurium, CW002, CW011, and Calabadion.神经肌肉阻滞与逆转的新药研发:甘他库铵、CW002、CW011和卡拉巴地翁。
Curr Anesthesiol Rep. 2018;8(2):119-124. doi: 10.1007/s40140-018-0262-9. Epub 2018 Mar 22.
3
Novel neuromuscular blocking drugs and antagonists.新型神经肌肉阻滞剂及拮抗剂。
Curr Opin Anaesthesiol. 2015 Aug;28(4):403-10. doi: 10.1097/ACO.0000000000000209.
4
History of the development of antagonists for neuromuscular blocking agents.神经肌肉阻滞剂拮抗剂的发展历史。
J Anesth. 2020 Oct;34(5):723-728. doi: 10.1007/s00540-020-02836-1. Epub 2020 Aug 7.
5
Sugammadex: Efficacy and Practicality in the Dental Office.舒更葡糖钠:在牙科诊所的疗效与实用性
Anesth Prog. 2018 Summer;65(2):113-118. doi: 10.2344/anpr-65-03-03.
6
Sugammadex: another milestone in clinical neuromuscular pharmacology.舒更葡糖钠:临床神经肌肉药理学的又一个里程碑。
Anesth Analg. 2007 Mar;104(3):575-81. doi: 10.1213/01.ane.0000244594.63318.fc.
7
Sugammadex: a cyclodextrin to reverse neuromuscular blockade in anaesthesia.舒更葡糖钠:一种用于逆转麻醉中神经肌肉阻滞的环糊精。
Expert Opin Pharmacother. 2008 Jun;9(8):1375-86. doi: 10.1517/14656566.9.8.1375.
8
Sugammadex: A Review of Neuromuscular Blockade Reversal.苏伽达ex:神经肌肉阻滞逆转的综述。
Drugs. 2016 Jul;76(10):1041-52. doi: 10.1007/s40265-016-0604-1.
9
A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.一项在七氟醚麻醉下给予 sugammadex 逆转深度罗库溴铵或维库溴铵诱发的神经肌肉阻滞的随机、剂量反应研究。
Anesth Analg. 2010 Jan 1;110(1):74-82. doi: 10.1213/ANE.0b013e3181c3be3c. Epub 2009 Nov 21.
10
Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.舒更葡糖钠逆转罗库溴铵和维库溴铵诱发神经肌肉阻滞的疗效:26 项研究的汇总分析。
J Clin Anesth. 2017 Sep;41:84-91. doi: 10.1016/j.jclinane.2017.06.006. Epub 2017 Jul 15.

引用本文的文献

1
Use of Muscle Relaxants in Emergency Medicine: A Review.急诊医学中肌肉松弛剂的应用:综述
Med Sci Monit. 2025 Sep 11;31:e949876. doi: 10.12659/MSM.949876.
2
Sugammadex for Neuromuscular Blockade Reversal: A Narrative Review.用于逆转神经肌肉阻滞的舒更葡糖:一项叙述性综述。
J Clin Med. 2025 Jun 11;14(12):4128. doi: 10.3390/jcm14124128.
3
Bibliometric Analysis of Research Trends and Global Collaborations in Anesthesia on Neuromuscular Blockers and Antagonists (2000-2024).麻醉领域中神经肌肉阻滞剂和拮抗剂的研究趋势与全球合作的文献计量分析(2000 - 2024年)
Healthcare (Basel). 2025 May 14;13(10):1146. doi: 10.3390/healthcare13101146.
4
Encapsulation of Vecuronium and Rocuronium by Sugammadex Investigated by Surface-Enhanced Raman Spectroscopy.通过表面增强拉曼光谱法研究舒更葡糖钠对维库溴铵和罗库溴铵的包封作用。
Molecules. 2025 Jan 9;30(2):231. doi: 10.3390/molecules30020231.
5
Supramolecular nanotherapeutics based on cucurbiturils.基于葫芦脲的超分子纳米疗法
J Nanobiotechnology. 2024 Dec 23;22(1):790. doi: 10.1186/s12951-024-03024-z.
6
Ensemble-Based Virtual Screening Led to the Discovery of Novel Lead Molecules as Potential NMBAs.基于集成的虚拟筛选导致发现新型潜在 NMBA 先导分子。
Molecules. 2024 Apr 24;29(9):1955. doi: 10.3390/molecules29091955.
7
Management of Neuromuscular Blocking Agents in Critically Ill Patients with Lung Diseases.肺部疾病重症患者神经肌肉阻滞剂的管理
J Clin Med. 2024 Feb 19;13(4):1182. doi: 10.3390/jcm13041182.
8
Nanotherapeutics for Alleviating Anesthesia-Associated Complications.用于缓解麻醉相关并发症的纳米治疗学。
Adv Sci (Weinh). 2024 Apr;11(15):e2308241. doi: 10.1002/advs.202308241. Epub 2024 Feb 11.
9
Efficacy and safety of adamgammadex for reversing rocuronium-induced deep neuromuscular blockade: A multicenter, randomized, phase IIb study.阿曲库铵诱导的深度神经肌肉阻滞逆转用氨甲酰基葡萄糖的疗效和安全性:一项多中心、随机、Ⅱb 期研究。
Clin Transl Sci. 2024 Jan;17(1):e13691. doi: 10.1111/cts.13691.
10
Influence of sugammadex versus neostigmine for neuromuscular block reversal on the incidence of postoperative pulmonary complications: a meta-analysis of randomized controlled trials.舒更葡糖钠与新斯的明用于逆转神经肌肉阻滞对术后肺部并发症发生率的影响:一项随机对照试验的荟萃分析
Perioper Med (Lond). 2021 Sep 20;10(1):32. doi: 10.1186/s13741-021-00203-6.